BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11214428)

  • 1. Primary pulmonary hypertension.
    Oliaro E; Grosso Marra W; Orzan F
    Minerva Cardioangiol; 2000 Nov; 48(11):361-78. PubMed ID: 11214428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epoprostenol in the treatment of portopulmonary hypertension].
    Culafić D; Culafić-Vojinović V; Jesić R
    Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary pulmonary hypertension in childhood: familial aspects].
    Squarcia U; Carano N; Agnetti A; Haitink O; Giovannelli G
    Pediatr Med Chir; 1981; 3(6):467-72. PubMed ID: 7343943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
    Humbert M; Labrune P; Simonneau G
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S93-6. PubMed ID: 12373580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary pulmonary hypertension].
    Svendsen UG; Andersen CB; Aldershvile J; Handberg J; Olsen PS
    Ugeskr Laeger; 1999 Feb; 161(7):935-40. PubMed ID: 10051801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary pulmonary hypertension and its management].
    Crespo Martínez C; Morales León V; Alonso Ramos H; Alonso Ortiz B; Molero Gómez R
    Farm Hosp; 2004; 28(1):48-55. PubMed ID: 15012178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
    Andreassen AK; Madsen S; Kjekshus J; Simonsen S
    Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary pulmonary hypertension: new treatment options].
    Madan S; Boonstra A; Berger RM
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1836-42. PubMed ID: 11593786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of portopulmonary hypertension.
    Tam NL; He XS
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):464-9. PubMed ID: 17897906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
    Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetics and physiopathology of primary or secondary pulmonary artery hypertension].
    Adnot S; Eddahibi S
    Bull Acad Natl Med; 2003; 187(8):1529-42; discussion 1543-5. PubMed ID: 15146583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of familial primary pulmonary hypertension in a 39-year-old female and her two children].
    Wozakowska-Kapłon B; Stepień-Wałek A; Błaszczyk A; Torbicki A
    Kardiol Pol; 2009 May; 67(5):521-5. PubMed ID: 19521938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
    van Albada ME; Berger RM; Niggebrugge M; van Veghel R; Cromme-Dijkhuis AH; Schoemaker RG
    Eur J Pharmacol; 2006 Nov; 549(1-3):107-16. PubMed ID: 16978602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension].
    Montani D; Hamid A; Yaïci A; Sztrymf B; Humbert M
    Rev Prat; 2004 Jan; 54(1):5-13. PubMed ID: 15049592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T; Eberle B; Guth S; Mayer E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iloprost for idiopathic pulmonary arterial hypertension.
    Leuchte HH; Behr J
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):215-23. PubMed ID: 15853595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.